Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Nutrigenomics industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Application trends
2.1.3. Distributional channel trends
2.1.4. Regional trends
Chapter 3. Nutrigenomics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing prevalence of obesity across the globe
3.3.1.2. Rising popularity for personalized diet
3.3.1.3. Increasing government initiatives on promoting health in developed regions such as North America and Europe
3.3.1.4. Rapid advances in molecular biology and genomics
3.3.2. Industry pitfalls & challenges
3.3.2.1. Stringent regulatory scenario
3.4. Growth potential analysis
3.4.1. By Application
3.4.2. By Distributional Channel
3.5. Porter’s analysis
3.6. Competitive landscape, 2018
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Nutrigenomics Testing Market, By Application
4.1. Key segment trends
4.2. Diabetes
4.2.1. Market size, by region, 2014-2025 (USD Million)
4.3. Obesity
4.3.1. Market size, by region, 2014-2025 (USD Million)
4.4. Cardiovascular Diseases
4.4.1. Market size, by region, 2014-2025 (USD Million)
4.5. Cancer
4.5.1. Market size, by region, 2014-2025 (USD Million)
4.6. Others
4.6.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Nutrigenomics Testing Market, By Distribution Channel
5.1. Key segment trends
5.2. Hospital & Clinics
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3. Online Platform
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4. Others
5.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Nutrigenomics Testing Market, By Region
6.1. Key regional trends
6.2. North America
6.2.1. Market size, by country, 2014-2025 (USD Million)
6.2.2. Market size, by application, 2014-2025 (USD Million)
6.2.3. Market size, by distribution channel, 2014-2025 (USD Million)
6.2.4. U.S.
6.2.4.1. Market size, by application, 2014-2025 (USD Million)
6.2.4.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.2.5. Canada
6.2.5.1. Market size, by application, 2014-2025 (USD Million)
6.2.5.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.3. Europe
6.3.1. Market size, by country, 2014-2025 (USD Million)
6.3.2. Market size, by application, 2014-2025 (USD Million)
6.3.3. Market size, by distribution channel, 2014-2025 (USD Million)
6.3.4. Germany
6.3.4.1. Market size, by application, 2014-2025 (USD Million)
6.3.4.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.3.5. UK
6.3.5.1. Market size, by application, 2014-2025 (USD Million)
6.3.5.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.3.6. France
6.3.6.1. Market size, by application, 2014-2025 (USD Million)
6.3.6.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.3.7. Spain
6.3.7.1. Market size, by application, 2014-2025 (USD Million)
6.3.7.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.3.8. Italy
6.3.8.1. Market size, by application, 2014-2025 (USD Million)
6.3.8.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.3.9. Russia
6.3.9.1. Market size, by application, 2014-2025 (USD Million)
6.3.9.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.4. Asia Pacific
6.4.1. Market size, by country, 2014-2025 (USD Million)
6.4.2. Market size, by application, 2014-2025 (USD Million)
6.4.3. Market size, by distribution channel, 2014-2025 (USD Million)
6.4.4. Japan
6.4.4.1. Market size, by application, 2014-2025 (USD Million)
6.4.4.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.4.5. China
6.4.5.1. Market size, by application, 2014-2025 (USD Million)
6.4.5.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.4.6. India
6.4.6.1. Market size, by application, 2014-2025 (USD Million)
6.4.6.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.4.7. Australia
6.4.7.1. Market size, by application, 2014-2025 (USD Million)
6.4.7.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.4.8. South Korea
6.4.8.1. Market size, by application, 2014-2025 (USD Million)
6.4.8.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.5. Latin America
6.5.1. Market size, by country, 2014-2025 (USD Million)
6.5.2. Market size, by application, 2014-2025 (USD Million)
6.5.3. Market size, by distribution channel, 2014-2025 (USD Million)
6.5.4. Brazil
6.5.4.1. Market size, by application, 2014-2025 (USD Million)
6.5.4.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.5.5. Mexico
6.5.5.1. Market size, by application, 2014-2025 (USD Million)
6.5.5.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.5.6. Argentina
6.5.6.1. Market size, by application, 2014-2025 (USD Million)
6.5.6.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.6. Middle East & Africa
6.6.1. Market size, by country, 2014-2025 (USD Million)
6.6.2. Market size, by application, 2014-2025 (USD Million)
6.6.3. Market size, by distribution channel, 2014-2025 (USD Million)
6.6.4. South Africa
6.6.4.1. Market size, by application, 2014-2025 (USD Million)
6.6.4.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.6.5. Saudi Arabia
6.6.5.1. Market size, by application, 2014-2025 (USD Million)
6.6.5.2. Market size, by distribution channel, 2014-2025 (USD Million)
6.6.6. UAE
6.6.6.1. Market size, by application, 2014-2025 (USD Million)
6.6.6.2. Market size, by distribution channel, 2014-2025 (USD Million)
Chapter 7. Company Profiles
7.1. Holistic Heal
7.1.1. Business overview
7.1.2. Financial data
7.1.3. Product landscape
7.1.4. Strategic outlook
7.1.5. SWOT analysis
7.2. CURA INTEGRATIVE MEDICINE
7.2.1. Business overview
7.2.2. Financial data
7.2.3. Product landscape
7.2.4. Strategic outlook
7.2.5. SWOT analysis
7.3. Nutrigenomix
7.3.1. Business overview
7.3.2. Financial data
7.3.3. Product landscape
7.3.4. Strategic outlook
7.3.5. SWOT analysis
7.4. GX Sciences
7.4.1. Business overview
7.4.2. Financial data
7.4.3. Product landscape
7.4.4. Strategic outlook
7.4.5. SWOT analysis
7.5. Interleukin Genetics
7.5.1. Business overview
7.5.2. Financial data
7.5.3. Product landscape
7.5.4. Strategic outlook
7.5.5. SWOT analysis
7.6. NutraGene
7.6.1. Business overview
7.6.2. Financial data
7.6.3. Product landscape
7.6.4. Strategic outlook
7.6.5. SWOT analysis
7.7. Metagenics
7.7.1. Business overview
7.7.2. Financial data
7.7.3. Product landscape
7.7.4. Strategic outlook
7.7.5. SWOT analysis
7.8. Pathway Genomics
7.8.1. Business overview
7.8.2. Financial data
7.8.3. Product landscape
7.8.4. Strategic outlook
7.8.5. SWOT analysis
7.9. Salugen
7.9.1. Business overview
7.9.2. Financial data
7.9.3. Product landscape
7.9.4. Strategic outlook
7.9.5. SWOT analysis
7.10. Gene Box
7.10.1. Business overview
7.10.2. Financial data
7.10.3. Product landscape
7.10.4. Strategic outlook
7.10.5. SWOT analysis
7.11. Xcode Life
7.11.1. Business overview
7.11.2. Financial data
7.11.3. Product landscape
7.11.4. Strategic outlook
7.11.5. SWOT analysis
7.12. Sanger Genomics
7.12.1. Business overview
7.12.2. Financial data
7.12.3. Product landscape
7.12.4. Strategic outlook
7.12.5. SWOT analysis
